Boston Scientific wins FDA approval for implantable heart devices

The Lowell Sun

NATICK — Boston Scientific Inc. said yesterday that the Food and Drug Administration approved several new implantable heart devices the company developed.

The company said the FDA approved devices that will be marketed under the names Incepta, Energen and Punctua devices.

All three product lines include implantable cardioverter defibrillators, which are used to treat rapid heartbeats, and cardiac resynchronization devices, which include an ICD and a resynchronization device used to coordinate the pumping of the heart.

The company said the devices are easier to implant and less visible from the outside than older devices.

Copyright 2011 MediaNews Group, Inc.
All Rights Reserved

Copyright © 2013 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.
Terms and Conditions Privacy Policy
Back to previous page

© Bound Tree Medical. All Rights Reserved.